Commercialisation as a Route to Clinical Impact – Workshop 1: Navigating the Pathway from Idea to Implementation
| Dates: | 13 September 2019 |
|---|
| Times: | 12:00 - 16:00 |
|---|
| What is it: | Workshop |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| Who is it for: | University staff |
|---|
|
The Manchester Molecular Pathology Innovation Centre (MMPathIC) - in collaboration with the Diagnostics and Technology Accelerator (DiTA) and NIHR Manchester Biomedical Research Centre (BRC) – is pleased to offer two half-day workshops that will allow participants to develop their awareness and understanding of commercialisation as a route to clinical impact.
Workshop Information
Understanding the regulatory route to market is key for successful commercialisation. These workshops are designed to give participants an overview of diagnostic test development, from the feasibility and patenting stages (Workshop 1), to the regulatory considerations one needs to be aware of if aiming for eventual uptake in the clinic (Workshop 2).
Workshop 1 Content - Navigating the Pathway from Idea to Implementation
• An introduction to intellectual property and protection strategies
• Generating economic evidence and defining the value proposition
• Building a business case to support adoption into the clinic
• The relationship between academia, clinicians, the NHS and industry
Prerequisites/ Audience
There are no prerequisites for attendance. These workshops have been designed to be accessible to anyone who has an interest in gaining a basic overview of the pathway from idea/need, to the implementation of diagnostics into the clinic.
We invite representation from industry, clinical specialities (including pathology and lab medicine), academics and researchers (biomedical and the engineering and physical sciences), business development professionals and other stakeholders with an interest in diagnostic development.
Register via Eventbrite
Travel and Contact Information
Find event
Citylabs 1.0
Nelson Street
Manchester
